[1] |
GERAGHTY R, WOOD K, SAYER JA. Calcium oxalate crystal deposition in the kidney: identification, causes and consequences[J]. Urolithiasis, 2020, 48(5):377-384. DOI: 10.1007/s00240-020-01202-w.
|
[2] |
HARAMBAT J, VAN STRALEN KJ, ESPINOSA L, et al. Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy[J]. Clin J Am Soc Nephrol, 2012, 7(3):458-465. DOI: 10.2215/CJN.07430711.
|
[3] |
LIESKE JC, MONICO CG, HOLMES WS, et al. International registry for primary hyperoxaluria[J]. Am J Nephrol, 2005, 25(3):290-296. DOI: 10.1159/000086360.
|
[4] |
COCHAT P, RUMSBY G. Primary hyperoxaluria[J]. N Engl J Med, 2013, 369(7):649-658. DOI: 10.1056/NEJMra1301564.
|
[5] |
TU X, ZHAO Y, LI Q, et al. Human miR-4660 regulates the expression of alanine-glyoxylate aminotransferase and may be a biomarker for idiopathic oxalosis[J]. Clin Exp Nephrol, 2019, 23(7):890-897. DOI: 10.1007/s10157-019-01723-8.
|
[6] |
BOUZIDI H, MAJDOUB A, DAUDON M, et al. Primary hyperoxaluria: a review[J]. Nephrol Ther, 2016, 12(6):431-436. DOI: 10.1016/j.nephro.2016.03.005.
|
[7] |
VALOTI E, ALBERTI M, CARRARA C, et al. Hemolytic uremic syndrome in an infant with primary hyperoxaluria type Ⅱ: an unreported clinical association[J]. Nephron, 2019, 142(3):264-270. DOI: 10.1159/000497823.
|
[8] |
HOPPE B. An update on primary hyperoxaluria[J]. Nat Rev Nephrol, 2012, 8(8):467-475. DOI: 10.1038/nrneph. 2012.113.
|
[9] |
CELLINI B, OPPICI E, PAIARDINI A, et al. Molecular insights into primary hyperoxaluria type 1 pathogenesis[J]. Front Biosci (Landmark Ed), 2012, 17:621-634. DOI: 10.2741/3948.
|
[10] |
CAI R, LIN M, CHEN Z, et al. Primary hyperoxaluria diagnosed after kidney transplantation failure: lesson from 3 case reports and literature review[J]. BMC Nephrol, 2019, 20(1):224. DOI: 10.1186/s12882-019-1402-2.
|
[11] |
SAS DJ, HARRIS PC, MILLINER DS. Recent advances in the identification and management of inherited hyperoxalurias[J]. Urolithiasis, 2019, 47(1):79-89. DOI: 10.1007/s00240-018-1093-3.
|
[12] |
ROOTMAN MS, MOZER-GLASSBERG Y, GUREVICH M, et al. Imaging features of primary hyperoxaluria[J]. Clin Imaging, 2018, 52:370-376. DOI: 10.1016/j.clinimag. 2018.09.009.
|
[13] |
ROBERSON NP, DILLMAN JR, O'HARA SM, et al. Comparison of ultrasound versus computed tomography for the detection of kidney stones in the pediatric population: a clinical effectiveness study[J]. Pediatr Radiol, 2018, 48(7):962-972. DOI: 10.1007/s00247-018-4099-7.
|
[14] |
梁少姗, 李丽娟, 徐峰, 等.移植肾草酸性肾病4例临床病理及预后分析[J].中国实用内科杂志, 2018, 38(8):770-773. DOI: 10.19538/j.nk2018080119.LIANG SS, LI LJ, XU F, et al. Clinical pathological characteristics and prognosis of oxalate nephropathy in the renal allograft: a report of four cases[J]. Chin J Pract Intern Med, 2018, 38(8):770-773. DOI: 10.19538/j.nk2018080119.
|
[15] |
RUMSBY G, WEIR T, SAMUELL CT. A semiautomated alanine:glyoxylate aminotransferase assay for the tissue diagnosis of primary hyperoxaluria type 1[J]. Ann Clin Biochem, 1997, 34 (Pt 4):400-404. DOI: 10.1177/000456329703400411.
|
[16] |
FILIPPOVA TV, SVETLICHNAYA DV, RUDENKO VI, et al. Genetic aspects of primary hyperoxaluria: diagnostics and treatment[J]. Urologiia, 2019(5):140-143.
|
[17] |
ABUKHATWAH MW, ALMALKI SH, ALTHOBAITI MS, et al. Primary hyperoxaluria type 1: a case report in an extended family with a novel AGXT gene mutation[J]. Medicine (Baltimore), 2020, 99(25):e20371. DOI: 10.1097/MD.0000000000020371.
|
[18] |
LUMB MJ, DANPURE CJ. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations[J]. J Biol Chem, 2000, 275(46):36415-36422. DOI: 10.1074/jbc.M006693200.
|
[19] |
YUEN YP, LAI CK, TONG GM, et al. Novel mutations of the AGXT gene causing primary hyperoxaluriatype 1[J]. J Nephrol, 2004, 17(3):436-440.
|
[20] |
KOTB MA, HAMZA AF, ABD EL KADER H, et al. Combined liver-kidney transplantation for primary hyperoxaluria type I in children: single center experience[J]. Pediatr Transplant, 2019, 23(1):e13313. DOI: 10.1111/petr.13313.
|
[21] |
BERGSTRALH EJ, MONICO CG, LIESKE JC, et al. Transplantation outcomes in primary hyperoxaluria[J]. Am J Transplant, 2010, 10(11):2493-2501. DOI: 10.1111/j.1600-6143.2010.03271.x.
|
[22] |
COCHAT P, HULTON SA, ACQUAVIVA C, et al. Primary hyperoxaluria type 1: indications for screening and guidance for diagnosis and treatment[J]. Nephrol Dial Transplant, 2012, 27(5):1729-1736. DOI: 10.1093/ndt/gfs078.
|
[23] |
DIEUDONNÉ Y, EPRINCHARD L, LÉON E, et al. Paraplegia as a presentation of primary hyperoxaluria[J]. CEN Case Rep, 2018, 7(2):313-315. DOI: 10.1007/s13730-018-0349-7.
|